Income Statement Patterson Companies, Inc.
Equities
PDCO
US7033951036
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.33 USD | +0.03% |
|
-.--% | - |
| 08/01 | Patterson Companies, Inc. Appoints Patrik Eriksson as North American President of Patterson Dental | CI |
| 22/25/22 | Patterson Companies, Inc. Announces Chief Executive Officer Changes | CI |
| Fiscal Period: April | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 549Cr | 591.21Cr | 649.94Cr | 647.15Cr | 656.83Cr | |||||
Total Revenues | 549Cr | 591.21Cr | 649.94Cr | 647.15Cr | 656.83Cr | |||||
Cost of Goods Sold, Total | 429.26Cr | 470.89Cr | 521.03Cr | 509.85Cr | 518.8Cr | |||||
Gross Profit | 119.74Cr | 120.31Cr | 128.91Cr | 137.29Cr | 138.02Cr | |||||
Selling General & Admin Expenses, Total | 101.13Cr | 99Cr | 109.28Cr | 108.92Cr | 111.35Cr | |||||
Other Operating Expenses, Total | 101.13Cr | 99Cr | 109.28Cr | 108.92Cr | 111.35Cr | |||||
Operating Income | 19Cr | 21Cr | 20Cr | 28Cr | 27Cr | |||||
Interest Expense, Total | -6.05Cr | -2.31Cr | -44.53L | -2.37Cr | -3.25Cr | |||||
Interest And Investment Income | - | 1.25Cr | 1.19Cr | 1.79Cr | 2.26Cr | |||||
Net Interest Expenses | -6.05Cr | -1.07Cr | 74.43L | -58.1L | -98.71L | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | 6L | -33.38L | -32.47L | -1.14Cr | -1.38Cr | |||||
EBT, Excl. Unusual Items | 13Cr | 20Cr | 20Cr | 27Cr | 24Cr | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -68Cr | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 3.43Cr | - | 10Cr | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | 36L | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Legal Settlements | -7.6Cr | - | -3.6Cr | - | - | |||||
EBT, Incl. Unusual Items | -59Cr | 20Cr | 27Cr | 27Cr | 24Cr | |||||
Income Tax Expense | -10.4L | 4.48Cr | 6.45Cr | 6.36Cr | 5.75Cr | |||||
Earnings From Continuing Operations | -59Cr | 16Cr | 20Cr | 21Cr | 19Cr | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | -59Cr | 16Cr | 20Cr | 21Cr | 19Cr | |||||
Minority Interest | 9L | 9L | 14.96L | 10L | 4L | |||||
Net Income - (IS) | -59Cr | 16Cr | 20Cr | 21Cr | 19Cr | |||||
Net Income to Common Incl Extra Items | -59Cr | 16Cr | 20Cr | 21Cr | 19Cr | |||||
Net Income to Common Excl. Extra Items | -59Cr | 16Cr | 20Cr | 21Cr | 19Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -6.25 | 1.63 | 2.09 | 2.14 | 2 | |||||
Basic EPS - Continuing Operations | -6.25 | 1.63 | 2.09 | 2.14 | 2 | |||||
Basic Weighted Average Shares Outstanding | 9.42Cr | 9.56Cr | 9.73Cr | 9.7Cr | 9.3Cr | |||||
Net EPS - Diluted | -6.25 | 1.61 | 2.06 | 2.12 | 1.98 | |||||
Diluted EPS - Continuing Operations | -6.25 | 1.61 | 2.06 | 2.12 | 1.98 | |||||
Diluted Weighted Average Shares Outstanding | 9.42Cr | 9.67Cr | 9.85Cr | 9.78Cr | 9.37Cr | |||||
Normalized Basic EPS | 0.85 | 1.32 | 1.3 | 1.73 | 1.64 | |||||
Normalized Diluted EPS | 0.85 | 1.3 | 1.29 | 1.71 | 1.63 | |||||
Dividend Per Share | 1.04 | 1.04 | 1.04 | 1.04 | 1.04 | |||||
Payout Ratio | -17.07 | 48.2 | 49.76 | 48.83 | 52.89 | |||||
Supplemental Items | ||||||||||
EBITDA | 27Cr | 29Cr | 28Cr | 37Cr | 35Cr | |||||
EBITA | 22Cr | 25Cr | 23Cr | 32Cr | 31Cr | |||||
EBIT | 19Cr | 21Cr | 20Cr | 28Cr | 27Cr | |||||
EBITDAR | 30Cr | 33Cr | 31Cr | 40Cr | 39Cr | |||||
Effective Tax Rate - (Ratio) | 0.18 | 22.42 | 24.24 | 23.53 | 23.67 | |||||
Current Domestic Taxes | 2.33Cr | 4.56Cr | 5.73Cr | 5.73Cr | 6.29Cr | |||||
Current Foreign Taxes | 75.01L | 99.75L | 1.2Cr | 82.8L | 82.01L | |||||
Total Current Taxes | 3.08Cr | 5.56Cr | 6.93Cr | 6.56Cr | 7.11Cr | |||||
Deferred Domestic Taxes | -3.2Cr | -1.04Cr | -45.01L | -45.94L | -1.56Cr | |||||
Deferred Foreign Taxes | 2L | -4L | -2L | 26.01L | 20.45L | |||||
Total Deferred Taxes | -3.18Cr | -1.08Cr | -47.18L | -19.93L | -1.35Cr | |||||
Normalized Net Income | 7.98Cr | 13Cr | 13Cr | 17Cr | 15Cr | |||||
Interest on Long-Term Debt | 4.18Cr | 2.43Cr | 2.03Cr | 3.36Cr | 4.49Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | 1L | 15.32L | 68.88L | 31.24L | |||||
Research And Development Expense From Footnotes | - | - | - | - | 1.17Cr | |||||
Net Rental Expense, Total | 3.63Cr | 3.47Cr | 3.56Cr | 3.56Cr | 3.85Cr | |||||
Imputed Operating Lease Interest Expense | 2.44Cr | 90.37L | 19.04L | 1.09Cr | 1.41Cr | |||||
Imputed Operating Lease Depreciation | 1.19Cr | 2.57Cr | 3.37Cr | 2.48Cr | 2.44Cr | |||||
Stock-Based Comp., SG&A Exp. (Total) | 2.29Cr | 2.12Cr | 2.38Cr | 1.55Cr | 1.79Cr | |||||
Stock-Based Comp., Other (Total) | 1.44Cr | 92.65L | - | - | - | |||||
Total Stock-Based Compensation | 3.74Cr | 3.05Cr | 2.38Cr | 1.55Cr | 1.79Cr |
- Stock Market
- Equities
- PDCO Stock
- Financials Patterson Companies, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















